Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Forms of Multiple Sclerosis”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Testing effectiveness (Phase 2)Ended earlyNCT01950234
What this trial is testing

ACTH in Progressive Forms of MS

Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple SclerosisProgressive Relapsing Multiple Sclerosis
University of Minnesota 59
Not applicableStudy completedNCT06251986
What this trial is testing

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 310
Testing effectiveness (Phase 2)Temporarily pausedNCT04909502
What this trial is testing

Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Emerald Health Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT05798520
What this trial is testing

Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Biogen 127
Not applicableStudy completedNCT02021162
What this trial is testing

Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple SclerosisHealthy
University at Buffalo 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06141473
What this trial is testing

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Sanofi 1,655
Early research (Phase 1)Ended earlyNCT01435993
What this trial is testing

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 3
Post-approval studies (Phase 4)Study completedNCT00536120
What this trial is testing

The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biogen 60
Early research (Phase 1)Ended earlyNCT01318421
What this trial is testing

ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 12
Testing effectiveness (Phase 2)Ended earlyNCT00595920
What this trial is testing

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingClinically Isolated Syndrome
Opexa Therapeutics, Inc. 116
Not applicableActive Not RecruitingNCT05688436
What this trial is testing

Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies

Who this might be right for
Multiple Sclerosis
Biogen 1,178
Early research (Phase 1)Study completedNCT02601885
What this trial is testing

A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AbbVie 20
Large-scale testing (Phase 3)Study completedNCT01127750
What this trial is testing

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

Who this might be right for
Relapsing Multiple Sclerosis
Novartis 2,417
Testing effectiveness (Phase 2)Study completedNCT00469378
What this trial is testing

Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 46
Testing effectiveness (Phase 2)Study completedNCT03737851
What this trial is testing

Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
AbbVie 208
Large-scale testing (Phase 3)Study completedNCT04121221
What this trial is testing

Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Mapi Pharma Ltd. 1,016
Early research (Phase 1)Active Not RecruitingNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Post-approval studies (Phase 4)Study completedNCT03856619
What this trial is testing

To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Sanofi 121
Large-scale testing (Phase 3)Ended earlyNCT00418145
What this trial is testing

Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

Who this might be right for
Multiple Sclerosis
Fred Lublin 16
Not applicableStudy completedNCT01070836
What this trial is testing

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Who this might be right for
Relapsing Multiple Sclerosis
Biogen 35,895
Next Page